国产成人精品一区二区色戒,www.四虎在线

熱門搜索化學(xué)品最多只顯示前20條，請(qǐng)點(diǎn)擊“搜索化學(xué)品”查看所有結(jié)果

CAS登錄號(hào)

中文名

英文名

分子結(jié)構(gòu)式

分子式

詳情

供應(yīng)商

59865-13-3

環(huán)孢菌素;
環(huán)孢素;
環(huán)胞霉素A

Cyclosporin A;
Antibiotic S 7481F1;
Cyclosporine

環(huán)孢菌素B;
環(huán)[L-丙氨酰-D-丙氨酰-N-甲基-L-亮氨酰-N-甲基-L-亮氨酰-N-甲基-L-纈氨酰-3-羥基-N,4-二甲基-L-2

Cyclosporin B;
Cyclo[L-alanyl-D-alanyl-N-methyl-L-leucyl-N-methyl-L-leucyl-N-methyl-L-valyl-3-hydroxy-N,4-dimethyl-L-2-amino-6-octenoyl-L-alanyl-N-methylglycyl-N-methyl-L-leucyl-L-valyl-N-methyl-L-leucyl]

環(huán)孢菌素D;
環(huán)[L-丙氨酰-D-丙氨酰-N-甲基-L-亮氨酰-N-甲基-L-亮氨酰-N-甲基-L-纈氨酰-3-羥基-N,4-二甲基-L-2

Cyclosporin D;
Cyclo[L-alanyl-D-alanyl-N-methyl-L-leucyl-N-methyl-L-leucyl-N-methyl-L-valyl-3-hydroxy-N,4-dimethyl-L-2-amino-6-octenoyl-L-valyl-N-methylglycyl-N-methyl-L-leucyl-L-valyl-N-methyl-L-leucyl]

佛羅里達(dá)白土,活性白土,血鮮紅質(zhì)

pyridinium, 1-((2-carboxy-8-oxo-7-(2-(2-thienyl)acetamido)-5-thia-1-azabicyclo( 4.2.0)o ct- 2-en-3-y;
Pyridinium,1-[[(6R,7R)-2-carboxy-8-oxo-7-[(2-thienylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl]-,inner salt (9CI);
Pyridinium,1-[[2-carboxy-8-oxo-7-[(2-thienylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl]-,hydroxide, inner salt, (6R-trans)-;
Pyridinium,1-[[2-carboxy-8-oxo-7-[2-(2-thienyl)acetamido]-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl]-,hydroxide, inner salt (8CI);
7-[a-(2-Thienyl)acetamido]-3-(1-pyridylmethyl)-3-cephem-4-carboxylic acidbetaine;
Aliporina;
Ampligram;
Cefaloridin;
Cefaloridine;
Ceflorin;
Cepaloridin;
Cepalorin;
Ceph 87/4;
Cephaloridin;
Cephaloridine;
Cephlodine;
Ceporan;
Ceporin;
Ceporine;
Cer;
Cilifor;
Deflorin;
Faredina;
Floridin;
Glaxoridin;
Intrasporin;
Keflodin;
Keflordin;
Kefspor;
Lilly 40602;
Lloncefal;
Loridine;
Pyridinium,1-[[2-carboxy-8-oxo-7-[(2-thienylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl]-,inner salt, (6R-trans)-;
Sch 11527;
Sefacin

Cyclosporin A,5-(N-methyl-D-valine)-6-(threo-3-hydroxy-N-methyl-L-leucine)- (9CI)

Cyclosporin A,2-[N6-[4-(1-diazo-2,2,2-trifluoroethyl)benzoyl]-D-lysine]- (9CI);
1,4,7,10,13,16,19,22,25,28,31-Undecaazacyclotritriacontane,cyclic peptide deriv.

Cyclosporin G,6-[(2S,3R,4R)-3-hydroxy-4-methyl-2-(methylamino)octanoic acid]- (9CI);
CyclosporinA, 6-[(3R,4R)-3-hydroxy-N,4-dimethyl-L-2-aminooctanoic acid]-7-L-norvaline-;
1,4,7,10,13,16,19,22,25,28,31-Undecaazacyclotritriacontane, cyclic peptidederiv.;
Cyclosporin G, dihydro-;
Dihydrocyclosporin G

Cyclosporin A,8-(N-methyl-D-serine)-;
1,4,7,10,13,16,19,22,25,28,31-Undecaazacyclotritriacontane,cyclic peptide deriv.;
SDZ 209-313

Cyclosporin V (9CI);
CyclosporinA, 1-(L-2-aminobutanoic acid)-;
1,4,7,10,13,16,19,22,25,28,31-Undecaazacyclotritriacontane, cyclic peptidederiv.;
Cyclo[D-alanyl-N-methyl-L-leucyl-N-methyl-L-leucyl-N-methyl-L-valyl-(3R,4R,6E)-6,7-didehydro-3-hydroxy-N,4-dimethyl-L-2-aminooctanoyl-L-2-aminobutanoyl-N-methylglycyl-N-methyl-L-leucyl-L-valyl-N-methyl-L-leucyl-L-2-aminobutanoyl]

Cyclosporin A,6-[(2E,5R,6R,7S)-6-hydroxy-5-methyl-7-(methylamino)-2-octenedioic acid]-;
CyclosporinA, 6-[(3R,4R,6E)-6,7-didehydro-3-hydroxy-N,4-dimethyl-L-2-aminooctanedioicacid]-;
1,4,7,10,13,16,19,22,25,28,31-Undecaazacyclotritriacontane, cyclicpeptide deriv.;
AM 1A;
Cyclosporin A metabolite 203-218;
M 203-218

Cyclosporin B,6-[(2S,3R,4R)-3-hydroxy-4-methyl-2-(methylamino)octanoic acid]- (9CI);
CyclosporinA, 6-[(3R,4R)-3-hydroxy-N,4-dimethyl-L-2-aminooctanoic acid]-7-L-alanine-;
1,4,7,10,13,16,19,22,25,28,31-Undecaazacyclotritriacontane, cyclic peptidederiv.;
Cyclosporin B, dihydro-;
Dihydrocyclosporin B

Cyclosporin A,6-[(2S,3R,4R,6E)-3-(acetyloxy)-4-methyl-2-(methylamino)-6-octenoic acid]-;
CyclosporinA, acetate (ester) (9CI);
1,4,7,10,13,16,19,22,25,28,31-Undecaazacyclotritriacontane, cyclic peptidederiv.;
B 3-243;
O-Acetyl-C91-cyclosporin A;
O-Acetylcyclosporin A;
SDZ 33-243

Cyclosporin A,6-[(2S,3R,4R)-3,8-dihydroxy-4-methyl-2-(methylamino)octanoic acid]- (9CI);
CyclosporinA, 6-[(3R,4R)-3,8-dihydroxy-N,4-dimethyl-L-2-aminooctanoic acid]-;
1,4,7,10,13,16,19,22,25,28,31-Undecaazacyclotritriacontane, cyclic peptidederiv.;
AM 1D1

Cyclosporin A,6-[(2S,3R,6E)-3-hydroxy-4,4-dimethyl-2-(methylamino)-6-octenoic acid]- (9CI);
CyclosporinA, 6-[(3R,6E)-6,7-didehydro-3-hydroxy-N,4,4-trimethyl-L-2-aminooctanoic acid]-;
1,4,7,10,13,16,19,22,25,28,31-Undecaazacyclotritriacontane, cyclic peptidederiv.;
L 674184

Cyclosporin A,9-(N-methyl-L-isoleucine)-;
1,4,7,10,13,16,19,22,25,28,31-Undecaazacyclotritriacontane,cyclic peptide deriv.;
NIM 811;
SDZ-NIM 811

Cyclosporin A,6-[(2S,3R,4R)-3-hydroxy-8-methoxy-4-methyl-2-(methylamino)octanoic acid]- (9CI);
CyclosporinA, 6-[(3R,4R)-3-hydroxy-8-methoxy-N,4-dimethyl-L-2-aminooctanoic acid]-;
1,4,7,10,13,16,19,22,25,28,31-Undecaazacyclotritriacontane, cyclic peptidederiv.;
SDZ 205-549

Cyclosporin A,2-[O-(2-hydroxyethyl)-D-serine]-;
1,4,7,10,13,16,19,22,25,28,31-Undecaazacyclotritriacontane,cyclic peptide deriv.;
Cyclo[[(2S,3R,4R,6E)-3-hydroxy-4-methyl-2-(methylamino)-6-octenoyl]-L-2-aminobutyryl-N-methylglycyl-N-methyl-L-leucyl-L-valyl-N-methyl-L-leucyl-L-alanyl-O-(2-hydroxyethyl)-D-seryl-N-methyl-L-leucyl-N-methyl-L-leucyl-N-methyl-L-valyl];
IMM 125;
Oxeclosporin;
SDZ-IMM 125

Cyclosporin A,6-[(2S,3R,4R,6E)-3,8-dihydroxy-4-methyl-2-(methylamino)-6-octenoic acid]-;
CyclosporinA, 6-[(3R,4R,6E)-6,7-didehydro-3,8-dihydroxy-N,4-dimethyl-L-2-aminooctanoicacid]-;
1,4,7,10,13,16,19,22,25,28,31-Undecaazacyclotritriacontane, cyclicpeptide deriv.;
7: PN: US6686454 SEQID: 7 claimed protein;
AM 1;
AM 1(peptide);
Cyclosporin A metabolite 17;
Cyclosporin AM 1;
Cyclosporinmetabolite 17;
M 17;
OL 17

Cyclosporin A,11-(N-methyl-L-alanine)-;
1,4,7,10,13,16,19,22,25,28,31-Undecaazacyclotritriacontane,cyclic peptide deriv.;
L 665890;
W 0-039

Cyclosporin D,6-[(2S,3R,4R)-3-hydroxy-4-methyl-2-(methylamino)octanoic acid]- (9CI);
CyclosporinA, 6-[(3R,4R)-3-hydroxy-N,4-dimethyl-L-2-aminooctanoic acid]-7-L-valine-;
1,4,7,10,13,16,19,22,25,28,31-Undecaazacyclotritriacontane, cyclic peptidederiv.;
Cyclosporin D, dihydro-;
Dihydrocyclosporin D

C63H115N11O12

詳情

供應(yīng)商

化工產(chǎn)品